Ask Me Anything: Cell-to-Cell Communication in Cancer

Join us for an interactive Ask Me Anything with Dr. Neil Bhowmick, a leading cancer biologist and translational researcher whose ground-breaking work is transforming our understanding of the tumor microenvironment and drug resistance in cancer. Dr. Bhowmick will answer your questions live, sharing unique insights and cutting-edge perspectives on the latest strategies reshaping cancer treatment. Whether you’re focused on translational research, clinical oncology, or drug development, this is your chance to engage directly with a pioneering leader in the field. Although the live Q&A format makes each session unique, anticipated discussion topics include: Understanding the tumor microenvironment and its role in treatment resistance How intercellular signaling drives drug resistance Current Standard of Care approaches to overcoming treatment resistance Innovative research on new drugs and therapies to prevent or reverse resistance Case studies in prostate and non-small cell lung cancers Whether you’re a scientist, clinician, policymaker, investor, or cancer research advocate, you will gain exclusive perspectives on cutting-edge strategies transforming cancer care. President & Chief Scientific Officer of Kairos Pharma A leading cancer biologist and translational researcher, Dr. Bhowmick is the Mark Goodson Oncology Research Chair and Professor in the Department of Medicine at Cedars-Sinai Medical Center. He also serves as the Chief Scientific Officer for Armida Labs as well as President of Enviro Therapeutics Inc. He completed a research fellowship at Vanderbilt University Medical Center. Dr. Bhowmick’s research has been continuously funded by the NCI/NIH for more than 20 years in the field of tumor microenvironment involving basic and clinical research for multiple cancer types.